Interleukin-2 (IL-2) to antiretroviral therapy (ART) does not confer any significant benefit in mortality in patients with HIV.
Pharmacokinetic assessment is a major component in choosing route of admission with antiretroviral agents for HIV infection.
Early antiretroviral therapy initiation may increase the rate of bone loss in HIV patients.
Treatment with antifungal drug amphotericin B is superior to itraconazole for HIV-associated talaromycosis.
Antiretroviral therapy may be the most consistent determinant of diabetes in patients with HIV.
A new study finds that not enough young MSM receive HIV testing despite accounting for most new diagnosis.
Financial incentives increase viral suppression in HIV-positive patients.
Patients with HIV and HIV-associated sensory neuropathy (HIV-SN) have reduced corneal nerve fiber density.
Tenofovir gel reduced the incidence of HIV infection by 61% in women with Lactobacillus-dominant vaginal flora but only 18% in women with non-Lactobacillus bacteria, according to a new study.
Researchers determined the factors affecting health-related quality of life in military HIV patients.
Dr Sara Gianella Weibel talks with Anthony B, a patient with HIV and end-stage amyotrophic lateral sclerosis and the first participant enrolled in the "Last Gift" end-of-life study, about his experience as part of this new end-of-life model to study HIV persistence.
Dr Sara Gianella Weibel talks with Dr Davey Smith, head of the Division of Infectious Disease at the University of California, San Diego, about a proposed new model to study HIV persistence, called the Last Gift study.
Critics of the FDA's current restriction on blood donation from MSM argue that it is unnecessary and discriminatory, and propose a policy based on individual risk rather than sexual orientation.
Drs Gianella and Karris discuss the many factors that play a role in the underrepresentation of women in HIV research.
A review of coronary heart disease in patients with HIV.
While 86% of all persons living with HIV in the US know that they are HIV-infected, only an estimated 35% actually achieve viral suppression.
Ramped up efforts to encourage more men who have sex with men to get tested for HIV have made an impact, but rates are still lower than needed.
The guidelines note that TB treatment should begin as soon as the patient is suspected of having active TB disease, even before test results confirm the diagnosis.
Gary Blick, MD, shares his 30+ years of experience in treating HIV.
Following the year-long study period, the intervention group had a testing rate of 63.7% and the comparison group had 42%.
SIGN UP FOR FREE E-NEWSLETTERS
Infectious Disease Advisor Articles
- Infections Complicate Biologic Use in Autoimmune Inflammatory Disorders
- Some Antibiotics May Reduce Biofilm in Urinary Tract Infections
- Tuberculosis Vaccine May Reverse Type 1 Diabetes
- Sepsis-Related Mortality Decreased With Rapid Implementation of Protocol
- New Assay Targets Susceptibility to Ciprofloxacin in Gonorrhea
- Increased Incidence of Chlamydia Due to Changes in Cancer Screening Guidelines
- Serratia marcescens Outbreak After Drug Tampering in US Hospital
- Meningococcal Disease Risk Linked to Eculizumab Despite Vaccination
- Medicaid Enrollees Largely Satisfied With Their Health Care
- Ebola Vaccine Long-Term Safety and Antibody Response